189 related articles for article (PubMed ID: 7055978)
21. Assay of the major bile acids in serum by isotope dilution-mass spectrometry.
Björkhem I; Falk O
Scand J Clin Lab Invest; 1983 Apr; 43(2):163-70. PubMed ID: 6351237
[TBL] [Abstract][Full Text] [Related]
22. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
Oftebro H; Björkhem I; Størmer FC; Pedersen JI
J Lipid Res; 1981 May; 22(4):632-40. PubMed ID: 6792308
[TBL] [Abstract][Full Text] [Related]
23. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
[TBL] [Abstract][Full Text] [Related]
24. Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
Kihira K; Shimazu K; Kuwabara M; Yoshii M; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
Steroids; 1986; 48(1-2):109-19. PubMed ID: 3660436
[TBL] [Abstract][Full Text] [Related]
25. Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis.
Björkhem I; Oftebro H; Skrede S; Pedersen JI
J Lipid Res; 1981 Feb; 22(2):191-200. PubMed ID: 7017048
[TBL] [Abstract][Full Text] [Related]
26. Biochemical abnormalities in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Berginer V
Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay compared to an enzymatic method for serum bile acid determination.
Samuelson K
Scand J Clin Lab Invest; 1980 May; 40(3):289-91. PubMed ID: 6934612
[TBL] [Abstract][Full Text] [Related]
28. Prediction of the bile acid composition of bile from serum bile acid analysis during gallstone dissolution therapy.
Whiting MJ; Watts JM
Gastroenterology; 1980 Feb; 78(2):220-5. PubMed ID: 7350043
[No Abstract] [Full Text] [Related]
29. Metabolism of potential precursors of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX).
Salen G; Shefer S; Mosbach EH; Hauser S; Cohen BI; Nicolau G
J Lipid Res; 1979 Jan; 20(1):22-30. PubMed ID: 438653
[TBL] [Abstract][Full Text] [Related]
30. Serum bile acid profile in thyroid dysfunction and effect of medical treatment.
Kosuge T; Beppu T; Kodama T; Hidai K; Idezuki Y
Clin Sci (Lond); 1987 Oct; 73(4):425-9. PubMed ID: 3665361
[TBL] [Abstract][Full Text] [Related]
31. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
32. Serum bile acid analysis.
Setchell KD; Matsui A
Clin Chim Acta; 1983 Jan; 127(1):1-17. PubMed ID: 6337748
[TBL] [Abstract][Full Text] [Related]
33. Identification of lithocholic acid and measurement of other bile acids in serum of healthy humans.
Pellizzari ED; O'Neil FS; Farmer RW; Fabre LF
Clin Chem; 1973 Feb; 19(2):248-52. PubMed ID: 4346071
[No Abstract] [Full Text] [Related]
34. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
[TBL] [Abstract][Full Text] [Related]
35. Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid.
Batta AK; Salen G; Shefer S; Tint GS; Batta M
J Lipid Res; 1987 Aug; 28(8):1006-12. PubMed ID: 3668385
[TBL] [Abstract][Full Text] [Related]
36. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis.
Bouwes Bavinck JN; Vermeer BJ; Gevers Leuven JA; Koopman BJ; Wolthers BG
Arch Dermatol; 1986 Nov; 122(11):1269-72. PubMed ID: 3777973
[TBL] [Abstract][Full Text] [Related]
37. Serum bile acids in patients with hyperlipidaemia.
Pennington CR; Ross PE; Bateson MC; Bouchier IA
J Clin Pathol; 1978 Jan; 31(1):58-62. PubMed ID: 627619
[TBL] [Abstract][Full Text] [Related]
38. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG
Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
[TBL] [Abstract][Full Text] [Related]
39. Chronic diarrhoea as a dominating symptom in two children with cerebrotendinous xanthomatosis.
van Heijst AF; Wevers RA; Tangerman A; Cruysberg JR; Renier WO; Tolboom JJ
Acta Paediatr; 1996 Aug; 85(8):932-6. PubMed ID: 8863874
[TBL] [Abstract][Full Text] [Related]
40. Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size.
Angelin B; Bjökhem I; Einarsson K
J Lipid Res; 1978 Jul; 19(5):527-37. PubMed ID: 670831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
